Incidence of thrombotic events in a population affected by Covid-19 in a general hospital in Veracruz, Mexico
Research and Practice in Thrombosis and Haemostasis Conference
; 6(Supplement 1), 2022.
Article
in English
| EMBASE | ID: covidwho-2128143
ABSTRACT
Background:
One of the main complications of Covid-19 are the thrombotic events reported with different incidences in the different case seriesAims:
To identify the incidence of thrombotic events in patients affected by Covid-19 in a general hospital in Veracruz, Mexico during April to October 2020. Method(s) Descriptive and retrospective study in which the thrombotic events presented by patients who suffered from Covid-19 during the period from April to October 2020 are analyzed. Result(s) Data from 1,212 patients diagnosed with Covid-19 are included, 641 (53%) men and 571 (47%) women, with a mean age of 49 years. 663 (54.7%) patients suffered from some chronic disease, systemic arterial hypertension was the most common comorbidity (29.2%), followed by diabetes (29.1%), obesity (13.9%), cardiovascular disease (5.4%), asthma (4.5 %), chronic kidney disease (3.8%) and COPD (2.1%). Six cases with various thrombotic events (50% venous and 50% arterial) were identified, predominantly in women (66%) and with mild Covid-19 (66%), of which 1 had a poor prognosis (severe Covid). The incidence of thrombotic events was 0.5% in this case series. Conclusion(s) Thrombotic events, although of low incidence, should always be taken into account during the follow-up of patients with both mild and severe Covid-19, since they add greater morbidity and mortality. (Table Presented).
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Observational study
Country/Region as subject:
Mexico
Language:
English
Journal:
Research and Practice in Thrombosis and Haemostasis Conference
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS